Catalyst Wire Dossier Catalyst Wire Dossier

Investigational insulin analogue (Phase 1)

insulin analogue · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational insulin analogue (Phase 1), covering 2017-07-13 to 2017-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy [Phase 1]

See pricing